Lanean...

Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin

BACKGROUND AND PURPOSE: In randomized trials, atrial fibrillation (AF) patients receiving dabigatran, a direct oral anticoagulant, had lower risk of intracranial bleeding (ICB) than those on warfarin. However, concerns exist about potential worse outcomes in dabigatran users if bleeding occurs, give...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Alonso, Alvaro, Bengtson, Lindsay, MacLehose, Richard, Lutsey, Pamela L., Chen, Lin Yee, Lakshminarayan, Kamakshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116615/
https://ncbi.nlm.nih.gov/pubmed/24994722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.006016
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!